AstraZeneca
AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company focused on oncology, cardiovascular, renal, metabolism, and respiratory therapies. AstraZeneca does not publish a general developer portal or commercial public APIs; technology integration is delivered through enterprise partner programs, clinical trial data portals such as clinicaltrials.gov and the Vivli platform, and EDI/x12 channels used by distributors and pharmacy benefit managers.
More than an index entry, but the surface is still mostly links rather than artifacts — the cohort most likely to move a full band from modest, well-targeted work.
API Evangelist profiles AstraZeneca the way a machine reads it — 10 machine-readable artifacts, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — AstraZeneca scores 16.4/100 (emerging), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile AstraZeneca
Each block below is one kind of artifact we hold for AstraZeneca. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Features 5
The notable capabilities this provider advertises, captured as structured features so they can be searched and compared instead of read one landing page at a time.
Notable capabilities this provider offers.
Clinical Trial Information
Clinical trial registrations and results are publicly accessible via clinicaltrials.gov, the EU Clinical Trials Register, and AstraZeneca's own trial site.
Patient-Level Data Sharing
Anonymized patient-level clinical trial data is made available to qualified researchers through the Vivli platform.
Medical Information Portal
Healthcare professionals can request product and safety information via country-specific medical information sites.
Distributor and Wholesaler EDI
Drug ordering, returns, chargebacks, and shipment notifications are exchanged with distributors via standardized x12 EDI transactions.
Pharmacovigilance Submissions
Adverse-event reports are received via regulatory channels (E2B, FAERS) rather than a public API.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Use Cases 4
What developers actually build with this provider — captured so the catalogue answers 'what is this for', not just 'what does this expose'.
What developers build with this provider.
Clinical Research Data Discovery
Find and link AstraZeneca-sponsored studies into clinical research and evidence-generation platforms.
Pharma Supply Chain Integration
Distributors integrate order, shipment, and chargeback flows with AstraZeneca's commercial supply chain via EDI.
Medical Affairs Engagement
HCPs and medical-information vendors retrieve dosing, contraindication, and interaction information for clinical decision support.
Real-World Evidence Studies
Researchers use the Vivli platform to combine AstraZeneca trial data with external real-world evidence sources.
Resources
Every other property we hold for AstraZeneca — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Get Started 1
Portal, sign-up, and the first successful call
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Other 2
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/astrazeneca · machine-readable index on apis.io